Companies similar to GT BIOPHARMA
Sign up to Download

1-30 of 9,895 results

  • www.gtbiopharma.com
  • 2
  • 6
Using our proprietary platform technology, GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin's lymphoma, acute myeloid leukemia and multiple solid tumors... GT..
Relevance: 39.146698
  • purinethol.com
  • 1
PURINETHOL (mercaptopurine) is indicated for maintenance therapy of acute lymphatic (lymphocytic, lymphoblastic) leukemia as part of a combination regimen. The response to this agent depends upon the particular subclassification of acute lymphatic..
Relevance: 28.045902
  • www.aikidopharma.com
  • 1
  • 1
AIkido Labs Inc. is a biotechnology development company working to develop a diverse portfolio of early and mid-stage small-molecule anti-cancer therapeutics. The AIkido Labs Inc. platform contains patented technology from leading universities and..
Relevance: 27.340733
  • www.catallyst.com
Recognizing the need for a comprehensive resource on measurable residual disease (MRD)... education, Amgen Oncology engaged with several opinion leaders in acute lymphoblastic leukemia... Review the latest information and resources on acute..
Relevance: 26.958069
  • acuteleuk.org
  • 7
  • 7
The Acute Leukemia Advocates Network (ALAN) is an independent global network of patient organisations, dedicated to changing outcomes of patients with acute leukemias by strengthening patient advocacy in that area. We aim to maximise the capacity of..
Relevance: 26.78703
  • cornellleukemia.com
  • 1
  • 7
Help Us Fight Leukemia How to donate to Leukemia Fighters Leukemia Fighters at NewYork-Presbyterian/Weill Cornell is devoted to the clinical and translational research projects of the Weill Cornell Leukemia Program. Leukemia Fighters was created by..
Relevance: 24.771276
  • www.leukemia-research.de
  • 6
  • 1
  • 27
Headed by Prof. Dr. Jan-Henning Klusmann and Prof. Dirk Heckl, we aim to understand the molecular basis underlying the development of myeloid leukemia. In order to achieve this goal and model this disease, we use state-of-the-art techniques including..
Relevance: 23.78125
  • www.benzenelawyers.com
  • 3
  • 1
Hughes Law Offices is NOT a general practice law firm. We are a national toxic tort law firm dedicated to serving people sickened by exposures to benzene... We are a law firm made up of toxic tort attorneys who serve victims of benzene exposures...
Relevance: 22.616016
  • www.tibsovopro.com
  • 2
TIBSOVO is a registered trademark of SERVIER PHARMACEUTICALS LLC, a wholly owned, indirect subsidiary of LES LABORATOIRES SERVIER... TIBSOVO® treatment for patients with Acute Myeloid Leukemia or Cholangiocarcinoma. See full indications, prescribing..
Relevance: 22.488123
  • www.managingaml.com
  • 2
Managing AML is a comprehensive educational initiative for hematologists/oncologists, pathologists, oncology pharmacists, oncology nurses and associated multidisciplinary clinicians who treat patients with acute myeloid leukemia (AML) across the..
Relevance: 22.488123
  • know-alleukemia.com
  • 1
  • 11
Know ALL is steered by an ambassador group of patients and caregivers, patient advocates, healthcare professionals, and industry representatives... Know ALL is a global education and awareness initiative that provides patients and caregivers with..
Relevance: 22.325085
  • makegoodmoves.com
  • 1
  • 1
In the fall of 2001, I was diagnosed with Acute Lymphoblastic Leukemia with Philadelphia Positive Chromosomes. On June 20, 2002, I had a bone marrow transplant. I lost 25% of my body weight and fell to a low of 138 lbs... About..
Relevance: 22.01593
  • besponsa.pfizerpro.com
  • 3
Find info on BESPONSA®, an Rx option for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). See risks benefits... BESPONSA offers convenient 1-hour dosing by IV infusion and can be administered in the outpatient..
Relevance: 21.90038
  • fadlcardaleukemia.org
  • 1
  • 2
  • 4
Fadlcarda Leukemia Foundation was founded in honor and loving memory of Baby Fadl Hamid. Fadl was 15months old when he was diagnosed with Acute Lymphoblastic Leukemia (ALL) in January 7 2016. After one session of chemotherapy, his doctor's at the..
Relevance: 21.474396
  • eln-david.org
  • 2
  • 3
ELN-DAVID is the international working group for MRD ASSESSMENT and VALIDATION in AML and is part of the European LeukemiaNet (ELN)... ELN David is an international working group par of the European LeukemiaNet and that promotes MRD assessment in..
Relevance: 21.431324
  • wugen.com
  • 2
  • 23
Our cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute..
Relevance: 21.204248
  • www.filo-leukemia.org
  • 2
The FILO association is implementing several approaches to achieve its objectives and progress in the treatment of hematology. Through its work and partnership with various organizations involved in this fight, case management and case studies are of..
Relevance: 20.675049
  • www.tecartushcp.com
TECARTUS is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the YESCARTA and TECARTUS REMS Program... TECARTUS is a CD19-directed genetically modified autologous T cell immunotherapy..
Relevance: 20.55101
  • med.stanford.edu
  • 14
  • 17
  • 53
The Majeti lab focuses on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly acute myeloid leukemia (AML). In parallel, the lab also investigates normal human..
Relevance: 20.083677
  • www.gigamune.com
GigaMune is a San Francisco biotechnology company developing a pipeline of in vivo cell therapies for cancer and inherited blood disorders... GigaMune is developing in vivo cell therapies for multiple myeloma, acute myeloblastic leukemia (AML), and..
Relevance: 19.71476
  • wntproteins.com
Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome... What are the most important things to consider when ordering a custom made recombinant protein?... Abstract Human embryonic..
Relevance: 19.574936
  • myeloidcancercures.usc.edu
  • 1
  • 2
  • 7
The Gehr CURES Myeloid Malignancy Program was established at the Keck School of Medicine of USC and the USC Norris Comprehensive Cancer Center in 2016 through the generosity of the Norbert Gehr Family Foundation. Our mission is to create "quantum..
Relevance: 19.540398
  • rjwangbioinfo.net
APA has been increasingly recognized as an important layer mRNA processing regulator which plays an important role in disease related process, such as tumorigenesis and neurological disorder. In this ongoing research, we have studied export factor..
Relevance: 19.333271
  • servier.us
  • 2
  • 19
As a growing leader in oncology, Servier is committed to finding solutions that will address today's challenges. The company's oncology portfolio of innovative medicines is designed to bring more life-saving treatments to a greater number of..
Relevance: 19.008408
  • grebienlab.com
  • 3
  • 1
  • 1
We believe that oncogenic mechanisms of AML fusion proteins are hard-wired in specific networks of physical, genetic and epigenetic interactions with key effector proteins. Functional exploration of these networks will provide new insights into..
Relevance: 18.981232
  • www.youandaml.com
  • 3
Peggy's story: How is your AML being monitored while you receive maintenance therapy?... This resource is intended for patients with acute myeloid leukemia (AML). You will find expert advice about AML to help you discuss key issues with your..
Relevance: 18.966267
  • www.mdsamlmatter.org
  • 1
  • 1
  • 8
To address the many challenges faced by members of the interdisciplinary care team involved in the diagnosis and treatment of patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), the American Society of Hematology (ASH),..
Relevance: 18.949095
  • aml-hub.com
  • 1
  • 1
  • 43
The AML Hub was founded in partnership with the European LeukemiaNet (ELN) in 2014. ELN is comprised of a network of top European specialists in the field of leukemia who are dedicated to research, training, and education. Together they look to..
Relevance: 18.812424
  • www.casinvent.com
  • 1
  • 1
The company CasInvent Pharma was established in 2020 as a spin-off of Masaryk University (MU) in cooperation with the investment partner i&i Prague, s.r.o. (Ltd). The mission of the company is to develop new therapeutic options for the treatment of..
Relevance: 18.54996
  • xospata.com
  • 1
XOSPATA is a prescription medicine used to treat adults with acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation when the disease has come back or has not improved after previous treatment(s). Your healthcare provider will..
Relevance: 18.259281